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Low doses of ivermectin cause 
sensory and locomotor disorders in 
dung beetles
José R. Verdú1, Vieyle Cortez1, Antonio J. Ortiz2, Estela González-Rodríguez3, Juan Martinez-
Pinna4, Jean-Pierre Lumaret5, Jorge M. Lobo6, Catherine Numa7 & Francisco Sánchez-
Piñero8
Ivermectin is a veterinary pharmaceutical generally used to control the ecto- and endoparasites of 
livestock, but its use has resulted in adverse effects on coprophilous insects, causing population 
decline and biodiversity loss. There is currently no information regarding the direct effects of 
ivermectin on dung beetle physiology and behaviour. Here, based on electroantennography and 
spontaneous muscle force tests, we show sub-lethal disorders caused by ivermectin in sensory 
and locomotor systems of Scarabaeus cicatricosus, a key dung beetle species in Mediterranean 
ecosystems. Our findings show that ivermectin decreases the olfactory and locomotor capacity of 
dung beetles, preventing them from performing basic biological activities. These effects are observed 
at concentrations lower than those usually measured in the dung of treated livestock. Taking into 
account that ivermectin acts on both glutamate-gated and GABA-gated chloride ion channels of 
nerve and muscle cells, we predict that ivermectin’s effects at the physiological level could influence 
many members of the dung pat community. The results indicate that the decline of dung beetle 
populations could be related to the harmful effects of chemical contamination in the dung.
Avermectins are macrocyclic fermentation products of Streptomyces avermilitis. Subsequent chem-
ical modifications resulted in the synthesis of ivermectin (22,23-dihydroavermectin B1), which is 
marketed as a mixture containing at least 80% 22,23-dihydroavermectin B1a and no more than 20% 
22,23-dihydroavermectin B1b1,2. Ivermectin is generally used to control the ecto- and endoparasites 
(mites and nematodes, mainly) of livestock and pets (dogs and cats)3,4. Ivermectin is also used in anti-
filarial chemotherapy in humans as it kills the immature worms (microfilariae) that cause the harmful 
symptoms of onchocerciasis5,6.
The mode of action of ivermectin is very effective, being 25 times more potent than all currently avail-
able veterinary pharmaceuticals6. The main physiological response to ivermectin is an increase in plasma 
membrane permeability due to an agonistic action on chloride channels present in nerve and muscle 
cells7. This effect results in a decreased membrane input resistance and hence in a reduced probability of 
action potential generation. Ivermectin acts as a positive allosteric regulator of several ligand-gated chan-
nels including γ –aminobutyric acid (GABA)-gated chloride channels and glutamate-gated chloride chan-
nel (GluCl). As these channels are inhibitory, the effect of ivermectin is a potentiation of the inhibitory 
1I.U.I. CIBIO, Universidad de Alicante, Alicante E-03080, Spain. 2Departamento de Química Inorgánica y Química 
Orgánica. Universidad de Jaén, Campus Las Lagunillas, Jaén E-23071, Spain. 3Departamento de Enfermería, 
Universidad de Alicante, Alicante E-03080, Spain. 4Departamento de Fisiología, Genética y Microbiología. 
Universidad de Alicante, Alicante E-03080, Spain. 5UMR 5175 CEFE, CNRS - Université de Montpellier - Université 
Paul-Valéry Montpellier – EPHE, Université Paul-Valéry Laboratoire Zoogéographie, route de Mende, 34199 
Montpellier cedex 5, France. 6Museo Nacional de Ciencias Naturales-CSIC, Departamento de Biogeografía y 
Cambio Global. José Abascal 2, Madrid E-28006, Spain. 7IUCN-Centre for Mediterranean Cooperation. Marie Curie 
22, Campanillas, Málaga E-29590, Spain. 8Departamento de Zoología, Universidad de Granada, Granada E-18071, 
Spain. Correspondence and requests for materials should be addressed to J.R.V. (email: jr.verdu@ua.es)
Received: 03 March 2015
Accepted: 07 August 2015
Published: 09 September 2015
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 5:13912 | DOi: 10.1038/srep13912
neurotransmission produced by GABA and glutamate in invertebrates, which culminates in a paralysis 
of somatic muscles8–10. GABA-gated chloride ion channels are present in neurons and abundant in local 
interneurons and antennal lobes of insects11–14 and are essential for olfactory processing. Evidence sug-
gests that GABA released from local interneurons activates GABA receptors in the presynaptic axon 
terminals of olfactory sensorial neurons-axons, leading to presynaptic inhibition and thereby reducing 
synaptic transmission. Recently, GABAB receptors have been observed in olfactory sensory neurons in 
the male antenna of Heliothis virescens, instantiating a GABA-mediated gain control mechanism that 
could play a pivotal role in processing pheromone signals15. Thus, due to its action on both GluCl and 
GABA ion channels, target organisms affected by ivermectin are generally ecto- and endoparasites of 
livestock, pets and humans; however, ivermectin sensitivity has been described as an ancient trait affect-
ing potentially all Ecdysozoan (moulting animals) species16.
After ivermectin is administered to mammals, its chemical decomposition by metabolism is generally 
low17,18, and between 62% and 98% of the ivermectin inoculated may be excreted as unchanged residue 
in faeces19,20. Unfortunately, ivermectin excreted by cattle, sheep, goats, swine, horses, etc. seems to have 
strong non-target effects on beneficial arthropods such as the arthropod community responsible for 
decomposing livestock dung. It is commonly recognised that adverse effects on coprophilous insects such 
as flies and beetles occur as a consequence of highly toxic concentrations of ivermectin in the dung of 
treated livestock19,21. Among non-target organisms, dung beetles are the most important group in terms 
of diversity, abundance, biomass and functional relevance (or ecosystem services) within the residents of 
dung pat communities22. For this reason, several studies on the ecotoxicology of ivermectin published 
during the last decades have focused on this group23. It is assumed that larvae of dung beetles are more 
sensitive to ivermectin residue (and that of other endectocides) than mature dung beetles21. In fact, some 
veterinary manuals indicate that mature dung beetles are usually unaffected by macrocyclic lactone res-
idues found in dung23. However, only scarce data exist about the direct effects of ivermectin on mature 
dung beetles. Currently, the published data refer to a few mortality cases of newly emerged adults and 
alteration of oviposition processes24–28. Many experimental studies have focused on breeding behaviour 
and offspring survival, but no data are available on the direct effects of ivermectin on the physiology and 
health status of mature dung beetles.
In this study, the model species was Scarabaeus cicatricosus Lucas, which was selected due to its local 
abundance and functional relevance in Mediterranean ecosystems. The genus Scarabaeus (Coleoptera, 
Scarabaeinae) includes 30 recognised species in the Palaearctic region29, all being large rollers that 
roll balls made of excrement far from the dung source for feeding or nesting. Studying the historical 
occurrence of the seven Scarabaeus species inhabiting the Iberian Peninsula, a previous investigation 
showed that these species have suffered a general decline30, also apparent in other European regions31–33. 
Scarabaeus cicatricosus is an endemic species mainly restricted to the Atlantic coast and sandy soils of the 
southwestern Iberian Peninsula, its populations being well established only within the Doñana Biological 
Reserve (DBR-ICTS), an ivermectin-free site within the Doñana National Park (Huelva) in southern 
Spain34,35. Taking into account that the use of ivermectin has been prohibited in this reserve and that 
the high abundance and biomass of this beetle species (approximately 1.5 grams of fresh weight) make 
it a keystone species from a functional perspective, we decided to use ‘healthy’ specimens of this species 
collected from uncontaminated localities to examine the effects of ingesting ivermectin. Thus, the exist-
ence of harmful effects of ivermectin on this species could support a probable role played by chemical 
contaminants in the decline of dung beetles.
We explored the sub-lethal symptoms and lethal consequences of ivermectin treatment in adults of 
this key dung beetle species using two different physiological methods combined with behavioural assays. 
Because ivermectin effects binding sites in GABA-gated chloride channels found in nervous system and 
olfactory sensory neurons (OSN) of insects, the first objective was to analyse the effect of this substance 
on the sensorial response of antennae using electroantennography (EAG). EAG is a method widely used 
in entomological research for the detection of volatiles perceived by the antennal olfactory apparatus of 
insects. In dung beetles, antennal clubs have the function of detecting food resources and close-range 
detection of sexual or aggregation signals36. If ivermectin affects OSN in dung beetles, we hypothesised 
that a decrease of antennal EAG responses would have to take place. Secondly, given that ivermectin 
acts on both glutamate-gated chloride ion channels and GABA-gated chloride ion channels in nerve and 
muscle cells generating paralysis of somatic muscles, we also aimed to examine the effect of ivermectin 
on the power output of synchronous walking leg muscles of dung beetles. In nematodes, exogenous glu-
tamate inhibits pharyngeal pumping, which is mimicked by ivermectin37, whereas paralysis of somatic 
muscles is associated with GABA-gated chloride channel receptors38. Ivermectin inhibits pharyngeal 
muscle contractions39,40, and in insects such as mosquitoes, ivermectin causes paralysis and mortality in 
adults41–43. Thus, we hypothesised that the ingestion of ivermectin by mature dung beetles could induce 
a decrease of muscle force contraction, possible ataxia and death. Finally, to complement the formerly 
mentioned physiological information, we carried out a complementary behavioural study using an olfac-
tometer bioassay, which combines testing both olfactory and locomotor (walking) capacities.
Results
Effect of ivermectin on the antennal olfactory apparatus. Electroantennography measurements 
showed that ivermectin ingestion negatively affected the antennal olfactory apparatus of S. cicatricosus 
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(Fig. 1 and supplementary Table S1). The concentration of ivermectin in the dung treatments was pos-
itively related to the quantity of ivermectin ingested per individual (R2 = 0.63; df = 1.13; P < 0.0001; 
n = 10), showing that the addition of different doses of ivermectin to the dung placed in the container 
effectively increased the concentration of ivermectin in the beetles. Statistically significant differences 
were found between the experimental treatments (F = 9.26; df = 6; P < 0.0001; n = 10), but neither body 
mass nor sex had a significant effect (P = 0.71 and P = 0.68, respectively; n = 10 in both cases). Post-hoc 
Dunnet’s tests indicated statistically significant differences between the control and all ivermectin treat-
ments being more significant from doses above 33.3 μ g kg–1 dung (fresh weight) (Fig. 1). This pattern was 
repeated when the ammonia odorant was used. Statistically significant differences between the experi-
mental groups were also obtained (F = 8.61; df = 6; P < 0.0001; n = 10), and neither body mass nor sex 
was significant (P = 0.19 and P = 0.76, respectively; n = 10 in both cases). Post-hoc Dunnet’s test showed 
significant differences between the control and strongest ivermectin treatments being more notable from 
doses of 100.0 μ g kg–1 dung (fresh weight) (Fig. 1).
Effect of ivermectin on spontaneous muscle force. Spontaneous isometric force decreased with 
ivermectin ingestion (Fig.  2 and supplementary Table S1). A clear relationship between ivermectin 
concentration in the treatment and the quantity of ivermectin ingested per individual was observed 
(R2 = 0.66; df = 1.52; P < 0.0001; n = 10). For SMF for the ‘Area’ variable (see methods section), signifi-
cant differences between the experimental groups were obtained (LogArea: F = 4.80; df = 6; P < 0.0001; 
n = 10), whereas body mass and sex were not significant (P = 0.41 and P = 0.97, respectively; n = 10 in 
both cases). Post-hoc Dunnet’s tests showed significant differences between the control and strongest 
ivermectin treatments being more significant from doses of 100.0 μ g kg–1 dung (fresh weight) (Fig.  2). 
This result was similar to those obtained for the ‘Peak’ variable showing significant differences between 
the experimental groups (LogPeak: F = 3.65; df = 6; P < 0.001; n = 10), whereas body mass and sex were 
not significant (P = 0.41 and P = 0.97, respectively; n = 10 in both cases). Post-hoc Dunnet’s tests showed 
significant differences between the control and both T100 and T200 (Fig.  2). The fact that both the 
average muscle force and the peak muscle force were affected suggests that ivermectin could alter the 
locomotory behaviour of beetles in the field.
Effect of ivermectin on foraging behaviour. Olfactometer tests showed a significant negative 
effect of ivermectin on foraging success (Fig.  3 and supplementary Table S1). The time elapsed to 
detect and to arrive at a food source increased significantly when the concentration of ivermectin was 
Figure 1. Ivermectin decreases the olfactory response of Scarabaeus cicatricosus. (a) Electroan- 
tennography recordings of an ivermectin-free individual (control) and an individual treated with application 
of ivermectin in dung (100 μ g kg–1 dung (fresh weight)) after exposure to hexane as a standard reference 
compound (green line) and two model odorants: ammonia (orange line) and trimethylamine (blue line). 
(b) Mean (± s.e.m.) data showing the effect of different ivermectin doses on sensitivity to ammonia (orange 
dots) and trimethylamine (blue dots). Six concentrations of 1.0, 3.3, 10.0, 33.3, 100.0, and 200.0 μ g kg–1 dung 
(fresh weight) plus an untreated control were used. Black dots correspond to ivermectin ingested for each 
treatment (*P < 0.05, **P < 0.01, ***P < 0.001, post-hoc Dunnet’s test). Photo credit: José R. Verdú.
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Figure 2. Ivermectin decreases the muscle force of Scarabaeus cicatricosus. (a) Spontaneous isometric 
muscle contraction recordings of an ivermectin-free individual (control) and an individual treated with 
application of ivermectin in dung (100 μ g kg–1 dung (fresh weight)). (b) Mean ( ±  s.e.m.) data showing the 
effect of different ivermectin doses on foreleg muscle force. The treatments correspond to 1.0, 3.3, 10.0, 33.3, 
100.0, and 200.0 μ g kg–1 dung (fresh weight) plus an untreated control. Yellow dots correspond to the area of 
spontaneous force generation above the resting level during a time interval of 5 minutes (in g ms–1); purple 
dots correspond to the peak (maximum value of spontaneous force; in g) during a time interval of 5 minutes 
(data are log10 transformed means ± s.e.m.; see text for statistical results); black dots correspond to the 
ivermectin ingested for each treatment (data are means ± s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001, post-hoc 
Dunnet’s test). Photo credit: José R. Verdú.
Figure 3. Ivermectin alters the foraging behaviour of Scarabaeus cicatricosus. Mean (± s.e.m.) data 
showing the negative effects of different ivermectin doses on the time required to detect and arrive at 
a food resource. Six concentrations of 1.0, 3.3, 10.0, 33.3, 100.0, and 200.0 μ g kg–1 dung (fresh weight) 
plus an untreated control were used. Red dots indicate the time required for 25% of individuals to arrive 
(t25%; 5 individuals); blue dots correspond to the time required for 50% of individuals to arrive (t50%; 10 
individuals) (data are means ± s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001, post-hoc Dunnet’s test).
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greater (Ft25% = 9.64, df = 6, P < 0.0001, n = 10; Ft50% = 8.11, df = 6, P < 0.0001, n = 10). t25% in post-hoc 
Dunnet’s tests showed significant differences between the control and strongest ivermectin treatments 
(Fig. 3). In the case of t50%, post-hoc Dunnet’s tests showed significant differences between the control 
and all ivermectin treatments (Fig. 3).
Lethal effects of ivermectin. Ingestion of ivermectin brought about a reduction in mobility, 
ataxia-paralysis and finally death in the adults of S. cicatricosus (Fig. 4 and supplementary Table S1). The 
time required to arrive at irreversible effects decreased as the dose of ivermectin increased (FAtaxia = 139.4, 
df = 6, P < 0.0001, n = 20; FDeath = 36.7, df =  6, P < 0.0001, n = 20). In both cases, post-hoc Dunnet’s tests 
showed significant differences between the control and all ivermectin treatments (Fig. 4).
Discussion
The sub-lethal and lethal effects of ivermectin residue on mature dung beetles were studied in terms 
of their physiology and behaviour. Ivermectin affects the antennal olfactory apparatus in S. cicatrico-
sus adults, decreasing their sensorial capacity markedly as the amount of ivermectin ingested increases. 
This result seems to be functionally related to the existence of ivermectin binding sites in GABA-gated 
chloride channels observed both in insect nervous system and olfactory sensory neurons15. Evidence 
about the presence of GABA-gated chloride ion channels in olfactory and mechanosensory organs in 
arthopods15,44,45 offers a new line of research exploring the mode of action and toxicology of ivermectin 
at the sensorial level. Our results show that the ingestion of very small doses of ivermectin is enough to 
considerably diminish the sensory capacity of individuals. The effective dose is appreciably lower than 
those usually measured in the dung of treated livestock. The concentration of ivermectin residue found in 
excreted dung varies according to the supply method, dosage and diet. For example, a reference study46 
found ivermectin concentrations of 117.8–243.8 μ g kg–1 dung (fresh weight) in fresh dung collected from 
animals 3 days after drug administration (500 μ g kg–1 bw, topical application), and 42.6–61.6 μ g kg–1 dung 
(fw) was found after 12 days. In a recent study47, the measured ivermectin concentration was 2.845 and 
2.480 mg kg–1 in dung (dry weight) (~355.6 and 310.0 μ g kg–1 dung fresh weight) collected from animals 
3 and 7 days, respectively, after drug administration (500 μ g kg–1 bw, topical application). After two 
weeks, the ivermectin concentration was still relatively high; 0.7 mg kg–1 (dry weight) (~ 86.5 μ g kg–1 
fresh weight). Even after 28 days, ivermectin was still detectable with 49.0 μ g kg–1 (dry weight) (~ 6.1 μ g 
kg–1 fresh weight). In our study, the lowest concentration of ivermectin used for treatment was notably 
lower (1.0 μ g kg–1 fresh weight equivalent to 0.022 ± 0.001 μ g individual–1 in our study) but still capable 
of adversely affecting the antennal olfactory apparatus. At higher concentrations (from 33.3 μ g kg–1 of 
fresh weight or 0.347 ± 0.029 μ g individual–1), we obtained stronger adverse effects even though these 
concentrations are markedly lower than those observed in the dung excreted by treated livestock. Thus, 
we provide the first evidence that environmentally realistic doses of ivermectin notably decrease the 
olfactory capacity of dung beetles, suggesting negative consequences on any activity that this sensorial 
apparatus facilitates, such as searching for food or a mate.
Furthermore, taking into account that ivermectin acts on both glutamate-gated chloride and 
GABA-gated chloride ion channels of nerve and muscle cells, inhibiting neurotransmission and result-
ing in paralysis of somatic muscles48,49, we also demonstrated the effect of ivermectin on neuromuscu-
lar activity. Our studies of spontaneous isometric contractions of foreleg muscles show that ivermectin 
Figure 4. Ivermectin causes paralysis and death of Scarabaeus cicatricosus. Mean (± s.e.m.) data showing 
the effect of different ivermectin doses on ataxia and subsequent death of individuals. Six concentrations of 
1.0, 3.3, 10.0, 33.3, 100.0, and 200.0 μ g kg–1 dung (fresh weight) plus an untreated control were used. Red 
dots correspond to the time required to cause ataxia, whereas blue dots indicate the time at which death 
occurred (data are means ± s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001, post-hoc Dunnet’s test).
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affected the muscle force in adults of S. cicatricosus, considerably reducing the magnitude of spontaneous 
isometric contractions as the quantities of ivermectin ingested increased. It has been reported that the 
negative effects of ivermectin on muscle contractions is due to its action on glutamate and GABA ion 
channels, both in nematodes such as Caenorhabditis elegans, Ascaris suum and Ascaridia galli40,50,51 and 
in some insects such as Drosophila melanogaster49, Schistocerca gregaria50 and Schistocerca americana52.
In the present study, negative effects of ivermectin on spontaneous isometric contractions of fore-
leg muscles were observed from 3.33 μ g kg–1 (fresh weight; equivalent to 0.020 ± 0.004 μ g individual–1), 
similarly to the olfactory response, and again at a lower level than concentrations previously observed in 
dung excreted by treated livestock. Furthermore, behavioural assays showed a strong negative effect of 
ivermectin on foraging behaviour with a clear decrease in the capacity to detect a food source and arrive 
at it (Fig. 3). As in other insect species such as D. melanogaster, ivermectin causes an acute decrease of 
mobility49.
Sub-lethal effects such as those observed in this study imply that mature beetles feeding on dung, 
even at low concentrations of ivermectin, experience an acute toxicity that prevents the performance 
of normal biological activities such as food detection, intraspecific communication, locomotion and 
interaction with the environment. There are available data on the lethal effects of ivermectin on other 
mature dung beetles. Ivermectin can cause mortality of adults in some species such as Copris ochus 
and Copris acutidens28. Other studies24,26 have demonstrated that ivermectin delays maturation and 
increases the mortality of newly emerged adults fed with dung from animals 2–16 days after treatment. 
However, information about the non-lethal but harmful effects of ivermectin on dung beetles is lacking. 
In the present contribution it has been shown that survival time decreases drastically as the amount of 
ingested ivermectin increases, and pre-lethal symptoms such as ataxia and paralysis also exist (Fig. 4). 
Unfortunately, many studies have focused on the effects of ivermectin on larval stages and breeding 
behaviour24–26,28,53–57 without carrying out standardised studies directed at mature stages. In some cases, 
mortality was not observed in adults, such as in Aphodius ater, Aphodius rufipes57, and Bubas bubalus24, 
whereas mortality was observed in newly emerged beetles in Copris hispanus, Onitis belial, Euoniticellus 
fulvus, and Onthophagus taurus24,26. Differences between larval and adult stages could be due to differ-
ences in feeding behaviour58, whereas differences among species regarding ivermectin sensitivity could 
be due to diverse ecological and phylogenetic factors that occur with dung-dwelling sepsid flies16. Given 
that all Ecdysozoa are potentially susceptible to ivermectin toxicity, that there are phylogenetic signals 
associated with ivermectin sensitivity, and that even closely related species may have very different nat-
ural sensitivities to ivermectin16, we suggest the necessity of further studies able to assess ivermectin 
sensitivity in different dung beetles species from a phylogenetic point of view considering a combination 
of physiological (sensorial and mechanical capacities) and behavioural analyses using mature beetles.
In conclusion, the results obtained here demonstrate that adult dung beetles are susceptible to iver-
mectin toxicity with detectable sub-lethal effects in physiological and behavioural tests. This approach 
shows that ivermectin markedly alters the sensorial and locomotor capacity of adult dung beetles, pre-
venting them from developing the most basic biological activities. In the case of this roller dung beetle 
species, the results suggest that the decline of these populations experienced across Europe might be 
related to the harmful effects of chemical contamination in dung due to the effects of avermectins. 
However, other veterinary medical products as organophosphates, which were commonly used in Europe 
during previous years may also contribute to the decline of Scarabaeus species59. From a practice point 
of view, we suggest the implementation of physiological testing in further eco-toxicological laboratory 
standardised tests58 to complement typical mortality tests (LC50 tests). Guidelines established by the 
International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary 
Medicinal Products (VICH; http://www.vichsec.org/) require an environmental risk assessment when 
animal excreted residues such as ivermectin are considered that adversely affect non-target organisms21. 
Therefore, we suggest that standardised tests are required, which incorporate more accurate analyses to 
test sub-lethal effects, using adult dung beetles to assess the sensorial and mechanical symptoms of novel 
veterinary pharmaceutical treatments.
Methods
Collection, selection and preparation of beetles. Individuals of S. cicatricosus were collected from 
the Doñana Biological Reserve (DBR-ICTS), an ivermectin-free site within the Doñana National Park 
(Huelva), in southern Spain during the summer (July 2013). All the individuals were maintained in plas-
tic containers (60 × 40 × 40 cm) at 20 °C until their arrival at the laboratory, where they were sustained 
in a climate chamber at 29 ± 1: 21 ± 1 °C (L: D), 80 ± 5 RH with a photoperiod of 14:10 (L : D). These 
conditions mimic optimal conditions experienced in the field34.
To assure a common physiological state for all of the individuals, thus allowing the comparison of 
physiological and behavioural measures among the treatments, we selected the following: (a) only mature 
specimens according to external age-grading methods (e.g., tibia and clypeus erosion) that permit the 
identification of individuals of approximately the same age60; (b) mature individuals of the same body 
mass (approximately 1.2 g); (c) a sex ratio of 1:1 in each experiment. This work conforms to the Spanish 
legal requirements including those relating to conservation and welfare. Additionally, beetle collection 
was conducted with relevant permissions related to collection and field study in the Doñana National 
Park.
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Collection and preparation of dung. Non-contaminated bovine dung was obtained from 
ivermectin-free cattle in the Doñana Biological Reserve. Fresh dung was collected during the first two 
hours of the morning to avoid dung fauna colonisation as well as to minimise physical-chemical changes 
in the dung. If not used immediately, dung was stored frozen (− 20 °C) or cold (3 °C) until its usage.
All the collected dung (~20 kg) was homogenised using an electric paint mixer. Ivermectin concen-
trations were selected according to literature and OECD recommendations54. Six concentrations of fresh 
dung, 1.0, 3.3, 10.0, 33.3, 100.0, and 200.0 μ g kg –1 plus an untreated control were used. Ivermectin solu-
tions were made by dissolving ivermectin (Sigma-Aldrich Co.) in absolute ethanol (Sigma-Aldrich Co.), 
and 2 ml aliquots of the six selected concentrations were added to 2 kg portions of fresh dung, mixing all 
for 20 min by means of a kitchen machine mixer. For the untreated control, absolute ethanol (2 ml) was 
applied to the same quantity of dung. Residual ethanol was removed by evaporation during the 6 hours 
before transferring the dung treatments to individual experimental units.
Ivermectin dosing. For electroantennography (EAG), foreleg muscle force and ataxia-mortality tests, 
each individual experimental unit consisted of a 15 × 10 × 7 cm plastic container using vermiculite as 
substrate. Dung treatments were supplied in 4 ml portions to better quantify the amount of ivermectin 
ingested per individual. Every three days, the dung not consumed was removed and measured (in ml), 
adding a new portion of the corresponding dung treatment. For EAG tests, beetles of each treatment 
were fed with treated dung for the 12 days before the bioassay was conducted. In the case of foreleg 
muscle force tests, the time of intoxication with ivermectin before bioassay was 12–18 days. For EAG 
and foreleg muscle force tests each treatment was replicated ten times and for ataxia-mortality tests 
each treatment was replicated twenty times. Beetles were numbered and weighed (body mass) prior 
to each treatment. In the case of olfactometer tests, beetles were also maintained in plastic containers 
(60 × 40 × 40 cm) with moist sterile vermiculite as substrate. Prior to testing, the beetles were supplied 
with dung during two weeks, replacing the dung every three days to ensure that the food supply was not 
a limiting factor. For this bioassay each treatment was replicated ten times.
Electroantennogram recordings. Electroantennogram signals were recorded with an EAG system 
(Syntech, Kirchzarten, Germany) consisting of a universal single ended probe (Type PRS-1), a stimulus 
controller (CS-55), a data acquisition interface board (Type IDAC-02), and a stimulus air controller 
(Type CS-01). The antennae of S. cicatricosus were excised, inserted into small droplets of electrode gel 
(Spectra 360, Parker Laboratories, Fairfield, NJ, USA) and mounted individually between the electrodes 
in an antenna holder under a purified air flow (500 ml/min) (Supplementary Figure S1). A Syntech 
PC-based signal processing system was used to amplify and process the EAG signals. The signals were 
further analysed using the EAG 2000 software (Syntech, Kirchzarten, Germany).
Stimulation tests were carried out by applying puffs of humidified air (200 ml/min) flowing for 2 s 
using a stimulus controller through a Pasteur pipette containing a small piece of filter paper (Whatman 
no. 1) strip (1 cm2) with 1 μ l of one of the test compounds flowing in a stainless steel delivery tube 
(1 cm diameter) with the outlet positioned at approximately 1 cm from the antenna. In each experi-
ment, the antenna was first presented with an injection of the standard reference compound, hexane 
(HPLC grade, Sigma-Aldrich Co.), and then with injections of test odorants. Based on highly specific 
sensitivity of insect olfactory sensory neuron (OSNs) to several compounds related to decomposition of 
protein-containing organic materials, such as ammonia and amines61, standards of ammonia (25% v/v 
aqueous solution, Merck KGaA, Darmstadt, Germany) and trimethylamine (45% v/v aqueous solution, 
Sigma-Aldrich Co.) were selected as test odorants. Puffs of the tested compounds were applied at 1 min 
intervals at least 10 times on each antenna. Replicates were performed with different individuals (n = 10 
for each treatment).
Measuring spontaneous muscle force. The beetle was firstly immobilised using a bandage of 
polytetrafluoroethylene (PTFE) around the thorax and abdomen. After cutting off one of the anterior 
forelegs to avoid undesired movements, the beetle was set on a Sylgard base chamber in a sideways 
position using insect pins piercing the PTFE around its body. The remaining foreleg of the beetle was 
attached to a force transducer by a surgical thread tied between the femur and the tibia (the knot being 
cemented with cyanoacrylate adhesive) (Supplementary Figure S2). When the beetle was properly posi-
tioned, the femur was vertical with its major axis perpendicular to the force transducer (FORT 250, 
WPI Inc. Stevenage, UK). The force transducer was mounted in a micromanipulator, which allowed 
stretching of the leg until it was just taut. Spontaneous muscle force (SMF) was measured, recording for 
each individual isometric contractions during a period of 5 minutes. At the beginning of this time the leg 
was stretched to a position that evoked a maximal contraction. LabChart v.7 software (ADInstruments 
Inc., Dunedin, New Zealand) running in a PowerLab 8/35 (ADInstruments Inc. Dunedin, New Zealand) 
was used for data acquisition. The maximum spontaneous force (‘Peak’ variable; in g) and the integral 
of area of the spontaneous force in time (‘Area’ variable; in g ms) were measured using Microcal Origin 
(Microcal Software Inc., Northampton, MA, USA). Replicates were performed using different individuals 
(n = 10 for each treatment).
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Olfactometer test. Four four-arm olfactometers were used to test the possible effects of ivermectin 
on the olfactory detection of dung and on locomotion capacity. The olfactometers consisted of a central 
arena with sterile dry vermiculite as a substrate and four 5-cm diameter holes to attach tubes (arms) 
containing plastic containers with the test samples at the ends (Supplementary Figure S3). These olfac-
tometers were developed and described in detail by Verdú et al.62. In this study, the plastic containers 
were designed to permit the entrance and exit of beetles that responded to the tested resources. In each 
olfactometer, two plastic containers were supplied with 20 g of fresh cattle dung and two empty con-
tainers were used as controls. Food sources were placed randomly in the olfactometer in each trial. The 
temperature in the bioassay room was maintained at 27–28 °C.
For each trial (n = 10 for each treatment), we counted the elapsed time that the beetles (20 beetles 
of each trial) took to go from the arena to the containers, measuring the time necessary to obtain both 
25% (t25%; 5 individuals) and 50% (t50%; 10 individuals).
Ataxia and mortality test. For each individual experimental unit described above, we supplied 4 
ml of dung (either control or treated dung). Every three days we tested possible negative symptoms 
related to ivermectin ingestion performing two observations: a) coordinated walking, and b) reflex avoid-
ance movements of the scape-pedicel joint of the antennae. When both observations were negative, we 
concluded that the beetle was healthy. Generally, both observations are sequential in time, thus if par-
tial paralysis (ataxia) was observed in the legs and or antennae, we noted the date of observation and 
described the symptoms. In this assay, each treatment was replicated twenty times (n = 20).
Statistical analyses. The data were analysed by an ANOVA design using General Linear Models 
(GLM) after log transformation of the dependent variables, if necessary, to follow a normal distribution. 
Normality was examined using a Kolmogorov-Smirnov test (P > 0.05 in all cases). Although the selec-
tion of beetles was made in order to reduce the variability of the body mass of individuals, we suspect 
that some differences in body mass among individuals may contribute to the random variability in the 
physiological measurements. Thus, we included body mass as a covariate in the analyses to reduce the 
error variance significantly. Multiple post-hoc comparisons between treatment groups against the con-
trol group were made using Dunnet’s tests (EAG test: mean of treatment < mean of control; SMF test: 
mean of treatment > mean of control; Olfactometer test: mean of treatment > mean of control; Ataxia 
and mortality test: mean of treatment > mean of control). The software STATISTICA v8.0 (StatSoft Inc, 
Tulsa, Oklahoma, USA) was used for all statistical analyses.
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